EN PL

EMA: Patients to discuss benefit-risk evaluation of medicines with the Committee for Medicinal Products for Human Use

02.10.2014
The European Medicines Agency (EMA) has launched a pilot project to involve patients in the assessment of the benefits and risks of medicines in its Committee for Medicinal Products for Human Use (CHMP).